These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30067278)

  • 21. The Occlutech Figulla PFO and ASD occluder: a new nitinol wire mesh device for closure of atrial septal defects.
    Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Hijazi Z; Jung C; Lauten A; Figulla HR
    J Invasive Cardiol; 2010 Apr; 22(4):182-7. PubMed ID: 20351390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.
    Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D
    Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conduction abnormality and arrhythmia after transcatheter closure of atrial septal defect.
    Komar M; Przewłocki T; Olszowska M; Sobień B; Stępniewski J; Podolec J; Mleczko S; Tomkiewicz-Pająk L; Zmudka K; Podolec P
    Circ J; 2014; 78(10):2415-21. PubMed ID: 25253507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous closure of patent foramen ovale and atrial septal defect in adults: the impact of clinical variables and hospital procedure volume on in-hospital adverse events.
    Opotowsky AR; Landzberg MJ; Kimmel SE; Webb GD
    Am Heart J; 2009 May; 157(5):867-74. PubMed ID: 19376313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.
    Manolis AS; Koulouris S; Rouska E; Pyrros J
    Indian Heart J; 2018; 70(1):24-31. PubMed ID: 29455783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of mid-term atrial geometrical and electrical remodeling following device closure of atrial septal defects in adults.
    Fang F; Luo XX; Lin QS; Kwong JS; Zhang YC; Jiang X; Yu CM; Lam YY
    Int J Cardiol; 2013 Sep; 168(1):467-71. PubMed ID: 23063142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leaving no hole unclosed: left atrial appendage occlusion in patients having closure of patent foramen ovale or atrial septal defect.
    Gafoor S; Franke J; Boehm P; Lam S; Bertog S; Vaskelyte L; Hofmann I; Sievert H
    J Interv Cardiol; 2014 Aug; 27(4):414-22. PubMed ID: 25059287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does transcatheter closure of patent foramen ovale really "shut the door?" A prospective study with transcranial Doppler.
    Anzola GP; Morandi E; Casilli F; Onorato E
    Stroke; 2004 Sep; 35(9):2140-4. PubMed ID: 15284445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspective.
    Singh V; Badheka AO; Patel NJ; Chothani A; Mehta K; Arora S; Patel N; Deshmukh A; Shah N; Savani GT; Rathod A; Manvar S; Thakkar B; Panchal V; Patel J; Palacios IF; Rihal CS; Cohen MG; O'Neill W; De Marchena E
    Catheter Cardiovasc Interv; 2015 May; 85(6):1073-81. PubMed ID: 25534392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-mid term follow-up results of percutaneous closure of the interatrial septal defects with occlutech figulla devices: a single center experience.
    Aytemir K; Oto A; Ozkutlu S; Kaya EB; Canpolat U; Yorgun H; Sahiner L; Kabakçi G
    J Interv Cardiol; 2012 Aug; 25(4):375-81. PubMed ID: 22612236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Przezskórne zamknięcie ubytku w przegrodzie międzyprzedsionkowej: wpływ na prawy przedsionek, dyspersję załamka P i zaburzenia rytmu serca w obserwacji średnioterminowej].
    Lelakowska M; Olszowska M; Matusik PT; Przewłocki T; Nessler J; Podolec N; Podolec P; Komar M
    Pol Merkur Lekarski; 2019 Mar; 46(273):109-114. PubMed ID: 30912518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elaborate evaluation of serial changes in electrocardiograms of atrial septal defects after transcatheter closure for a better understanding of the recovery process.
    Kang MJ; Sawatari H; Chishaki H; Shinbara R; Yamasaki K; Sato T; Fujita K; Sakamoto I; Hiasa KI; Ishikita A; Umemoto S; Nishizaka M; Tsutsui H; Kamiya CA; Niwa K; Chishaki A
    Heart Vessels; 2020 Nov; 35(11):1594-1604. PubMed ID: 32468142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40 years.
    Wang JK; Chiu SN; Lin MT; Chen CA; Lu CW; Wu MH
    Heart Vessels; 2017 Apr; 32(4):467-473. PubMed ID: 27531005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amplatzer left atrial appendage occlusion through a patent foramen ovale.
    Koermendy D; Nietlispach F; Shakir S; Gloekler S; Wenaweser P; Windecker S; Khattab AA; Meier B
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1190-6. PubMed ID: 24399612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term impact of transcatheter closure interatrial shunts on disabling migraine.
    Rigatelli G; Pasquetto G; Zuin M
    Acta Cardiol; 2024 Jul; 79(5):575-581. PubMed ID: 38818761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term safety and efficacy of combined percutaneous LAA and PFO/ASD closure: a single-center experience (LAAC combined PFO/ASD closure).
    Yu J; Liu X; Zhou J; Xue X; Muenzel M; Schulze PC; Moebius-Winkler S; Keil T; Meng Z; Tang S
    Expert Rev Med Devices; 2019 May; 16(5):429-435. PubMed ID: 30999776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P-wave dispersion between transcatheter and surgical closure of secundum-type atrial septal defect in childhood.
    Baspinar O; Sucu M; Koruk S; Kervancioglu M; Ustunsoy H; Deniz H; Kilinc M
    Cardiol Young; 2011 Feb; 21(1):15-8. PubMed ID: 20920379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supraventricular Arrhythmia Following Patent Foramen Ovale Percutaneous Closure.
    Guedeney P; Laredo M; Zeitouni M; Hauguel-Moreau M; Wallet T; Elegamandji B; Alamowitch S; Crozier S; Sabben C; Deltour S; Obadia M; Benyounes N; Collet JP; Rouanet S; Hammoudi N; Silvain J; Montalescot G
    JACC Cardiovasc Interv; 2022 Nov; 15(22):2315-2322. PubMed ID: 36008269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies.
    Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of aortic valve regurgitation and outcome after percutaneous closure of atrial septal defects and patent foramen ovale.
    Schoen SP; Boscheri A; Lange SA; Braun MU; Fuhrmann J; Kappert U; Strasser RH
    Heart; 2008 Jul; 94(7):844-7. PubMed ID: 18070946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.